CCHT(SZ:000661) Sou Hu Cai Jing·2025-06-21 02:48Group 1: Investment Funds and Initiatives - Changchun Xinghe Runxin Venture Capital Center, initiated by CITIC Construction Investment and several partners, has been registered with the Asset Management Association of China, focusing on the biomedical industry in Jilin Province [2] - A total scale of 1 billion yuan industrial software special fund was signed at the 2025 Nanjing Software Conference, highlighting the importance of industrial software in digital transformation and smart manufacturing [3] - Zhongke Chuangxing successfully issued a 400 million yuan targeted technology innovation bond, with a 2.10% interest rate, showcasing market confidence in its investment strategy [4] Group 2: Market Trends and Performance - The number of innovative drugs approved in China increased from 3 in 2015 to 39 in 2024, marking a 12-fold increase and positioning China as the second globally in innovative drug approvals [8] - The total amount of cross-border business development transactions by Chinese pharmaceutical companies reached 63.5 billion USD in 2024, a year-on-year increase of 22.59% [8] - The Hang Seng Technology Index rose by 14.9%, significantly outperforming major global markets, indicating a strong recovery in the Hong Kong capital market [8] Group 3: Strategic Developments - Zhengzhou Economic Development Zone's first industrial venture capital mother fund has been registered, with a total scale of 5 billion yuan, focusing on sectors like new energy and high-end intelligent equipment [9][10] - The Xiong'an Artificial Intelligence Industrial Park aims to create a comprehensive ecosystem for AI innovation, supported by a 10 billion yuan investment fund [10][11] - Wuhan's government has released an action plan to enhance the development of technology finance, optimizing the evaluation mechanism for government investment funds [12]